[图书][B] Cancers broncho-pulmonaires: vérités polémiques et nouveautés futures
B Lebeau - 1999 - books.google.com
Le cancer du poumon n'existe pas (anatomopathologie)………………………………... 15 De
la difficulté d'être anatomopathologiste 15 De la difficulté de classer les cancers …
la difficulté d'être anatomopathologiste 15 De la difficulté de classer les cancers …
[图书][B] Fibrinolysis in Disease-The Malignant Process, Interventions in Thrombogenic Mechanisms, and Novel Treatment Modalities, Volume 2
P Glas-Greenwalt - 2019 - books.google.com
Fibrinolysis in Disease reviews the state of the art of basic and clinical aspects of the
fibrinolytic enzyme system. The text, authored by outstanding and internationally known …
fibrinolytic enzyme system. The text, authored by outstanding and internationally known …
Bifunctional inhibitors of urokinase and metalloproteinase-9 for cancer treatment-in silico evaluation
SP Brewer, J Jankun - … The University of Toledo Journal of …, 2018 - openjournals.utoledo.edu
Abstract Matrix metalloproteinase-9 (MMP-9), and urokinase plasminogen activator (uPA)
overexpression or/and increased activity are considered causative elements for cancer …
overexpression or/and increased activity are considered causative elements for cancer …
The Coagulation-Cancer Interaction in Situ
LR Zacharski, VA Memoli - Tumor Matrix Biology (1995), 2017 - taylorfrancis.com
This chapter focuses on the information of coagulation-cancer interaction in situ that
provides a basis for formulation of key hypotheses for future testing. The heterogeneity of …
provides a basis for formulation of key hypotheses for future testing. The heterogeneity of …
Overcoming Transport Barriers To Nanoparticle-Based Chemotherapy
A Kirtane - 2015 - conservancy.umn.edu
Targeted delivery of drugs to tumors is critical for optimal implementation of chemotherapy.
Targeted drug delivery can be achieved by encapsulating drugs in nanometer-sized drug …
Targeted drug delivery can be achieved by encapsulating drugs in nanometer-sized drug …
[PDF][PDF] MEMORIA DE LA PLATAFORMA DE ONCOLOGÍA AÑO 2010
PDELAP DE ONCOLOGÍA - plataformadeoncologia.com
Durante el pasado año USP-Hospitales ha sido adquirido por el Grupo Hospitalario Quirón,
quedando fusionados en una única empresa desde Julio 2012. El Grupo Hospitalario …
quedando fusionados en una única empresa desde Julio 2012. El Grupo Hospitalario …
[PDF][PDF] Thromboembolic prophylaxis for oncological patients-general recommendations
P Chernopolsky, V Bozhkov… - Scripta Scientifica …, 2010 - journals.mu-varna.bg
_MZU ZOd YO hQ UP\M e abze {zzzzz\Z SYMOSRg Lnh P [[QUR YO wzexzc P] TPR\Y SZX
YjMd\Z SYMOSR dM\MOd YO^ PO STM UMZ RPO] PU TPR\Y SZX YjZ SYPOg| M [ZQRM] …
YjMd\Z SYMOSR dM\MOd YO^ PO STM UMZ RPO] PU TPR\Y SZX YjZ SYPOg| M [ZQRM] …
[图书][B] Heparins, cancer and thrombosis: clinical and experimental studies
SM Smorenburg - 2000 - dare.uva.nl
Recent randomized trials have suggested that treatment with low molecular weight heparin
(LMWH) improves survival of cancer patients with venous thromboembolism, as compared …
(LMWH) improves survival of cancer patients with venous thromboembolism, as compared …
Vitamin K antagonists (VKA) Experimental studies
G Lugassy, A Falanga, AK Kakkar… - Thrombosis and …, 2004 - api.taylorfrancis.com
In animal experiments, positive effects have been reported with thrombolytic agents. Here
the emphasis has been on metastasis, and not so much on effects on the primary tumor …
the emphasis has been on metastasis, and not so much on effects on the primary tumor …
[引用][C] Специфическая аллерговакцинация-приоритетное направление профилактики рецидивов аллергических заболеваний
ЛР Выхристенко, ОВ Смирнова, ВВ Янченко - Медицинские новости, 2007 - elibrary.ru
В статье изложены современные взгляды на специфическую аллерговакцинацию как
наиболее эффективный, экономически выгодный способ профилактики рецидивов …
наиболее эффективный, экономически выгодный способ профилактики рецидивов …